August 23, 2010
Roche acquires BioImagene, a leading provider of digital pathology laboratory solutions

Mannheim/ Basel (D/ CH) | Acquisition further strengthens Roche’s global leadership in tissue-based cancer diagnostics and research

August 18, 2010
Annual Conference of The Technopolicy Network - Annual Conference of The Technopolicy Network - 29. 09 - 01. 10

World Experts on Regional Innovation gather in Heidelberg: Join the Annual Conference of The Technopolicy Network!

www.technopolicy.net/annualconference

 

August 04, 2010
Glycotope Received Regulatory Approval for Glycooptimized and Fully Human Glycosylated Antibody CetuGEX™ and Enrolls First Patients in Clinical Trial

Berlin (G) | Glycotope GmbH, a leading glycobiology company, has received regulatory approval by German and Italian regulatory authorities for a Phase I study of Glycotope´s next generation antibody CetuGEX™ (GT-MAB 5.2-GEX) for the treatment of various solid cancers. «For Glycotope, the approval of...

July 15, 2010
One Million for Cancer Research: Manfred Lautenschläger Foundation supports the development of new vaccines against cancer

Heidelberg (G) | When Harald zur Hausen was awarded the Nobel Prize for Medicine in 2008, Manfred Lautenschläger spontaneously offered to support the Nobel laureate’s scientific work by funding a new research team. These funds will now go to Angelika Riemer, a young scientist who plans to advance th...

June 23, 2010
febit Announces Operational Restructuring

Heidelberg (Germany and Lexington) | Strategic focus on partnerships with clinical researchers, diagnostic and pharma industry for its microRNA (miRNA) biomarker technology

June 04, 2010
Life Technologies Partners with German Cancer Research Center to Create World-Class Genome Sequencing Facility

CARLSBAD (USA)/ Heidelberg (G) | Life Technologies Corporation (NASDAQ: LIFE) and the German Cancer Research Center (Deutsches Krebsforschungszentrum or DKFZ), today announced their collaboration to create the National High-Throughput Sequencing Center. This exclusive partnership will create the lar...

May 27, 2010
Data Published in Nature Confirms Development of APG101 to Treat Cancer

Heidelberg (G) | Peer-Reviewed Publication by Professor Marcus Peter of the University of Chicago Shows Cancer Cells Depend on the Constitutive Activity of CD95, Stimulated by Cancer-Produced CD95L.

May 21, 2010
Increased Cancer Risk of People with Type 2 Diabetes

Heidelberg (G) | Scientists of the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) have published the largest study worldwide on the combined risk of diabetes and cancer. People affected by type 2 diabetes have an elevated risk of 24 of the types of cancer studied. The effect ...

May 06, 2010
Fatty Acid To Enhance Anticancer Drug

Scientists of the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) have discovered that bioavailability and efficacy of the blood cancer drug azacytidine increase when the substance is coupled to a fatty acid.

April 29, 2010
Affimed raises 20 million Euro in a Series C financing round

Heidelberg (G) | Affimed Therapeutics AG, the therapeutic TandAb antibody company, today announced the successful closing of a Series C financing round of 20 million Euro.

April 27, 2010
Second Biomarker Expert Meeting in Heidelberg

Heidelberg (G) | Novel biomarkers enable innovative approaches in diagnostics and therapy for cancer and cardiovascular diseases

April 23, 2010
Intelligent Pharma opens first international office in Heidelberg

The Catalan biotech company Intelligent Pharma opened their first international office in Heidelberg on the 13th of April to strengthen their presence in the European market. For their first international branch, the Technologie Park Heidelberg was selected as it is located in an important area for ...

April 19, 2010
Medicyte GmbH Benefits From Multi-Million Euro EU Grant VascuBone

Medicyte has been elected partner in the VascuBone project, in which 15 European partners from industry and academic institutions work on practical, yet individual solutions in bone regenerative medicine. The VascuBone project is supported by a 12 million Euro FP7 grant from the European Union start...

April 14, 2010
Movies for the human genome - EMBL scientists identify the genes involved in cell division in humans

Name a human gene, and you’ll find a movie online showing you what happens to cells when it is switched off. This is the resource that researchers at the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany, and their collaborators in the Mitocheck consortium are making freely availab...

March 19, 2010
A Delegation from BioRN Cluster Management GmbH Visits TCI Secretariat

A delegation from German TCI organizational member BioRN Cluster Management GmbH visited the TCI Secretariat in Barcelona on 11 March 2010, to present their cluster initiative and web-based cluster management tool.